Sandler Capital Management’s Usana Health Sciences USNA Stock Holding History

Sandler Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-108,000	Closed	-$6.24M	–	107
2020 Q1	$6.24M	Sell	108,000 -102,000	-49%	-$7.09M	0.86%	48
2019 Q4	$16.5M	Buy	+210,000	New	+$15.5M	1.89%	20
2019 Q3	–	Sell	-200,000	Closed	-$15.9M	–	151
2019 Q2	$15.9M	Buy	+200,000	New	+$15.9M	1.06%	30
2013 Q3	–	Sell	-398,800	Closed	-$14.4M	–	220
2013 Q2	$14.4M	Buy	+398,800	New	+$12.1M	0.54%	76

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sandler Capital Management's USNA Position: Q4 2014 in Review

Sandler Capital Management sold out of Usana Health Sciences (USNA) in Q4 2014, closing a stake of 44,828 shares — an estimated $1.65M sold.

Sandler Capital Management first reported a position in USNA in Q2 2013 and held it in 6 quarters. The position peaked at $1.98M in Q3 2013. 131 funds tracked by Wall St. Rank hold USNA as of Q4 2014.

Sandler Capital Management reported no remaining Usana Health Sciences position as of Q4 2014 after selling out during the quarter.
Sandler Capital Management sold 44,828 Usana Health Sciences shares in Q4 2014, an estimated $1.65M.
Sandler Capital Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 6 quarters.
Sandler Capital Management's Usana Health Sciences position peaked at $1.98M in Q3 2013.
131 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2014.

Based on Sandler Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.